Drug News in Oncology area.

Drug News in Oncology area. http://www.lifescience-online.com/ News Feed Powered by Lifescience-online.com en-us Wed, 08 Feb 2012 03:49:16 +0100 Wed, 08 Feb 2012 03:49:16 +0100 News Lifescience-online http://rss.lifescience-online.com/images/logo.gif http://www.lifescience-online.com/ Lifescience-online Merck and Threshold Announce Global Agreement to Co-Develop and Commercialize Phase III Hypoxia-Targeted Drug TH-302 http://www.lifescience-online.com/Merck_and_Threshold_Announce_Global_Agreement_to_C,30781.html?portalPage=Lifescience+Today.News

Area :: Oncology
Category :: Partnerships and Licensing
Related companies :: MERCK KGAA
THRESHOLD PHARMACEUTICALS INC
Related drugs :: TH-302

]]> Thu, 02 Feb 2012 23:00:00 GMT News FDA approves Novartis drug Glivec(R) label recommending extending treatment to three years for certain GIST patients after surgery http://www.lifescience-online.com/FDA_approves_Novartis_drug_Glivec__label_recommend,30767.html?portalPage=Lifescience+Today.News

Area :: Oncology
Category :: Scientific - Pipeline - Regulatory
Related companies :: NOVARTIS AG
Related drugs :: IMATINIB MESYLATE

]]> Tue, 31 Jan 2012 23:00:00 GMT News AB Science Reports Positive Clinical Study Data: Masitinib Significantly Extends Overall Survival as compared to Pfizer?s Sutent(R) in Gleevec(R)-resistant GIST http://www.lifescience-online.com/AB_Science_Reports_Positive_Clinical_Study_Data__M,30768.html?portalPage=Lifescience+Today.News

Area :: Oncology
Category :: Scientific - Pipeline - Regulatory
Related companies :: AB SCIENCE
Related drugs :: MASITINIB

]]> Tue, 31 Jan 2012 23:00:00 GMT News Medivation and Astellas Announce Positive Results From the Phase 3 AFFIRM Trial of MDV3100 in Prostate Cancer Patients Who Received Prior Chemotherapy http://www.lifescience-online.com/Medivation_and_Astellas_Announce_Positive_Results_,30765.html?portalPage=Lifescience+Today.News

Area :: Oncology
Category :: Scientific - Pipeline - Regulatory
Related companies :: ASTELLAS PHARMA INC
MEDIVATION INC
Related drugs :: MDV-3100

]]> Mon, 30 Jan 2012 23:00:00 GMT News FDA Approves Erivedge (Vismodegib) Capsule, the First Medicine for Adults with Advanced Basal Cell Carcinoma http://www.lifescience-online.com/FDA_Approves_Erivedge__Vismodegib__Capsule__the_Fi,30756.html?portalPage=Lifescience+Today.News

Area :: Oncology
Category :: Scientific - Pipeline - Regulatory
Related companies :: GENENTECH INC
ROCHE HOLDING LTD
Related drugs :: VISMODEGIB

]]> Sun, 29 Jan 2012 23:00:00 GMT News Curis Announces FDA Approval of Erivedge(TM) (vismodegib) Capsule as First Treatment for Advanced Basal Cell Carcinoma http://www.lifescience-online.com/Curis_Announces_FDA_Approval_of_Erivedge_TM___vism,30771.html?portalPage=Lifescience+Today.News

Area :: Oncology
Category :: Scientific - Pipeline - Regulatory
Related companies :: CURIS INC
Related drugs :: VISMODEGIB

]]> Sun, 29 Jan 2012 23:00:00 GMT News ZIOPHARM Oncology Announces Recommendation by Independent Data Monitoring Committee to Continue Phase 3 Study of Palifosfamide in Metastatic Soft Tissue Sarcoma http://www.lifescience-online.com/ZIOPHARM_Oncology_Announces_Recommendation_by_Inde,30775.html?portalPage=Lifescience+Today.News

Area :: Oncology
Category :: Scientific - Pipeline - Regulatory
Related companies :: ZIOPHARM ONCOLOGY INC
Related drugs :: PALIFOSFAMIDE

]]> Sun, 29 Jan 2012 23:00:00 GMT News Cell Therapeutics, Inc. (CTIC) Withdraws New Drug Application for Pixuvri(TM) and Plans to Resubmit in 2012 http://www.lifescience-online.com/Cell_Therapeutics__Inc___CTIC__Withdraws_New_Drug_,30727.html?portalPage=Lifescience+Today.News

Area :: Oncology
Category :: Scientific - Pipeline - Regulatory
Related companies :: CELL THERAPEUTICS INC
Related drugs :: PIXANTRONE DIMALEATE

]]> Sun, 29 Jan 2012 23:00:00 GMT News